Microfluidic captured patient-derived circulating endothelial cells identify novel targets of pulmonary arterial hypertension
- 19 May 2025
- journal article
- Published by Elsevier in Biomaterials
- Vol. 323, 123429
Abstract
No abstract availableKeywords
Funding Information
- Cardiovascular Medical Research and Education Fund
- University of Texas at El Paso
This publication has 56 references indexed in Scilit:
- Mechanotransduction via endothelial adhesion molecule CD31 initiates transmigration and reveals a role for VEGFR2 in diapedesisImmunity, 2023
- Endothelial cell senescence exacerbates pulmonary hypertension by inducing juxtacrine Notch signaling in smooth muscle cellsiScience, 2023
- Developmental diversity and unique sensitivity to injury of lung endothelial subtypes during postnatal growthiScience, 2023
- Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cellsAngiogenesis, 2020
- An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic CandidatesCancer Cell, 2020
- 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLTThe Journal of Heart and Lung Transplantation, 2019
- Biodegradable nano-films for capture and non-invasive release of circulating tumor cellsBiomaterials, 2015
- Design and validation of an endothelial progenitor cell capture chip and its application in patients with pulmonary arterial hypertensionJournal of Molecular Medicine, 2011
- Endothelial Cell Energy Metabolism, Proliferation, and Apoptosis in Pulmonary HypertensionComprehensive Physiology, 2011
- Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppelJournal of Molecular Biology, 1999